Red Thread
Red Thread Consulting is a UK-based boutique consultancy providing pharmaceutical medical writing and regulatory submission support — including CSRs, protocols, NDAs/BLAs/MAAs, and agency responses — to pharma, medical device, and regulatory consultancy clients globally.
- Company typePrivate
- Founded2012
- HeadquartersMarlow, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Red Thread does
Red Thread Consulting Limited is a privately held UK pharmaceutical medical writing and regulatory consulting firm, founded in 2012 and operating from Marlow, United Kingdom. The company delivers expert clinical document development, process consulting, and project governance for drug development and clinical trial programs, including protocol writing, clinical study report (CSR) development, and regulatory submission support spanning NDAs/BLAs/MAAs, CTAs/INDs, scientific advice, orphan applications, briefing books, and agency responses. Its documented work includes successful regulatory submissions to the World Health Organization and multiple international regulatory authorities.
The firm targets three verticals: pharmaceutical companies (primary), medical device companies, and regulatory consultancies. Client engagement is direct, enterprise-level, and project-based, with services delivered under agreed project budgets. Acquisition is driven by business development, testimonials, and reputation within the pharmaceutical and medical device industries rather than any formal marketing or channel program; no pricing is publicly disclosed.
Operationally, Red Thread is a small (1-10 employees), founder-led consultancy without disclosed institutional investment, parent company, subsidiaries, partnerships, patents, or technology platform. Core delivery is concentrated in the principal (Katharine) and a small senior team, leveraging decades of regulatory leadership experience. The company has no publicly disclosed revenue, headcount, funding, M&A activity, or product launches in the source material.
Red Thread firmographics
Firmographics- Name
- Red Thread
- Legal name
- Red Thread Consulting Limited
- Website
- https://red-thread-consulting.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Red Thread Consulting is a UK-based boutique consultancy providing pharmaceutical medical writing and regulatory submission support — including CSRs, protocols, NDAs/BLAs/MAAs, and agency responses — to pharma, medical device, and regulatory consultancy clients globally.
- Ownership category
- akta.pro rank
Red Thread industry classification
Industry- Product category
- Pharmaceutical Regulatory Consulting
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)
- akta.pro secondary industry
- Medical Writing & Clinical Documentation FSP (HLAGAOAC)
Keywords
Where Red Thread is headquartered
LocationHeadquarters
- HQ city
- Marlow
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Red Thread business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Professional Services - Medical Writing and Regulatory Consulting: The company generates revenue through consulting engagements for medical writing, protocol writing, clinical study report development, and regulatory submission support. Services are delivered on a project basis with agreed budgets, typically for pharmaceutical and medical device companies requiring regulatory documentation expertise.
Go-to-market motion1 record
Distribution channels1 record
Red Thread product offering
Product offeringCore offering
Red Thread Consulting Limited provides medical writing and regulatory consulting services for pharmaceutical and medical device companies. Core deliverables include protocol writing, clinical study reports (CSRs), regulatory submission documents (NDA, BLA, MAA, CTA, IND), scientific advice, orphan drug applications, and briefing books for global submissions.
Product overview
Red Thread Consulting is a specialized regulatory and medical writing consultancy that provides a unified service offering centered on clinical document development for pharmaceutical and life sciences companies. The core service is Medical Writing, which encompasses protocol writing, clinical study report (CSR) development, and regulatory submission support. The company operates as a single-service consultancy rather than a platform with modular products, offering integrated consulting, process guidance, and project governance alongside its medical writing capabilities to support clients throughout the drug development lifecycle.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Writing Services
Quantifiable outcome
- Reduced regulatory agency inquiries during drug development process
Companies that use Red Thread
Customer profileSegments3 records
Ideal customer profiles2 records
Red Thread technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Red Thread partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Expansion highlights3 records
Red Thread competitors and assessment
Company assessmentBroad incumbents
- Medpace: Mid-to-large CRO with in-house medical writing and regulatory documentation teams supporting full-service clinical trials. Comparable writing capabilities but bundled into a full-service CRO contract model.
- Ergomed: CRO with a specialized pharmacovigilance and medical writing services offering alongside full-service clinical development. Comparable in regulatory writing scope but smaller and more specialized than top-tier CROs.
- ICON plc: Major global CRO with dedicated medical writing and regulatory services functions. Comparable in submission support capability but operates at much larger scale and across the full clinical development lifecycle.
- Worldwide Clinical Trials: Mid-sized CRO with medical writing and regulatory submission services across multiple therapeutic areas. Comparable in writing deliverables but operates as a full-service CRO with broader clinical operations footprint.
- Premier Research: Global CRO with dedicated medical writing and regulatory services. Comparable in regulatory submission and CSR work, especially in specialty therapeutics, though significantly larger and broader in scope.
- IQVIA: Largest CRO with embedded medical writing and regulatory submission teams serving pharma and biotech. Competes for the same enterprise-level writing work Red Thread targets but as part of a far broader services portfolio.
- Parexel: Large global CRO offering medical writing and regulatory submission support as part of broader clinical development services. Overlaps with Red Thread in CSR/protocol writing but covers biometrics, monitoring, and full-service clinical operations.
Direct peers
- Synchrogenix (Certara): Specialized regulatory and medical writing services within Certara, focused on submissions, CSRs, and protocol writing for pharma. Closely comparable in service offering and target buyer, though embedded within a larger technology-enabled platform.
- Trilogy Writing & Consulting: Specialized medical writing and regulatory documentation consultancy serving pharma and biotech. Highly comparable to Red Thread in service scope (CSRs, protocols, regulatory submissions) and boutique, expert-led delivery model.
- Cactus Communications (CACTUS): Global scientific and medical writing services provider with pharma regulatory writing offerings. Comparable as a direct competitor in medical/regulatory writing for life sciences clients, though at significantly larger scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Red Thread social profiles
Digital presenceRed Thread financial estimates
Financial estimateRevenue estimate
Valuation estimate
Red Thread leadership team
Management profileNumber of profiles
Red Thread funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Red Thread M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Red Thread
What does Red Thread do?
Red Thread Consulting Limited provides medical writing and regulatory consulting services for pharmaceutical and medical device companies. Core deliverables include protocol writing, clinical study reports (CSRs), regulatory submission documents (NDA, BLA, MAA, CTA, IND), scientific advice, orphan drug applications, and briefing books for global submissions.
Is Red Thread a public or private company?
Red Thread is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Red Thread founded?
Red Thread was founded in 2012. It employs 1 to 10 people.
Where is Red Thread based?
Red Thread is headquartered in Marlow, United Kingdom, in the Europe region.
How does Red Thread make money?
One revenue line is on record: professional Services - Medical Writing and Regulatory Consulting.
Who are Red Thread's main competitors?
Broad incumbents on record are Medpace, Ergomed, ICON plc, Worldwide Clinical Trials, Premier Research, IQVIA and Parexel. Direct peers are Synchrogenix (Certara), Trilogy Writing & Consulting and Cactus Communications (CACTUS).
Does Red Thread have an API?
No public API is recorded for Red Thread.
What industry is Red Thread in?
Red Thread's product category is Pharmaceutical Regulatory Consulting. Its primary akta.pro industry code is HLAGAAAG, Medical Writing & Regulatory Submission Support CROs, with a secondary code of HLAGAOAC, Medical Writing & Clinical Documentation FSP. Its NAICS code is 54169 and its SIC code is 8742.